[Effects of FDA 20 infusion on endocrine function in surgical patients (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001802:Blood Substitutes / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D005260:Female; D005466:Fluorocarbons / Q000494:pharmacology*; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D013514:Surgical Procedures, Operative; D014667:Vasopressins / Q000097:blood*
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; D014667:Vasopressins; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D013006:Growth Hormone